Epithalon vs Pinealon

Epithalon

Epithalon (also known as Epitalon or epithalamin) is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) developed by Vladimir Khavinson at the Saint Petersburg Institute of Bioregulation and Gerontology in Russia. Its primary mechanism of action involves activation of telomerase, the enzyme responsible for adding telomeric repeats (TTAGGG) to chromosome ends, thereby counteracting the progressive telomere shortening associated with cellular aging. Published research by Khavinson and colleagues (Bulletin of Experimental Biology and Medicine, 2003) demonstrated that epithalon increased telomerase activity in human somatic cells and extended the replicative lifespan of fibroblast cultures beyond the Hayflick limit. In animal studies, chronic epithalon use in aging rats was associated with increased lifespan and restoration of melatonin secretion rhythms from the pineal gland, which naturally declines with age (Anisimov et al., Mechanisms of Ageing and Development, 2003). The peptide also appears to modulate expression of genes involved in antioxidant defense and circadian rhythm regulation. Compared to other telomerase activators such as TA-65 (a small molecule derived from astragalus), epithalon is a direct peptide bioregulator with a well-characterized tetrapeptide sequence. Research also suggests potential effects on retinal health, with studies indicating photoreceptor preservation in aging retinal models. Store lyophilized powder at -20C protected from moisture; reconstitute with bacteriostatic water and refrigerate at 2-8C for up to 21 days. Epithalon is studied by gerontology research centers, telomere biology laboratories, and chronobiology departments investigating age-related decline in pineal gland function.

Pinealon

Pinealon is a synthetic tripeptide with the sequence Glu-Asp-Arg (EDR) that belongs to the Khavinson peptide bioregulator family. It was designed to target pineal gland function, and research suggests it penetrates cell membranes and interacts directly with DNA, modulating gene expression related to neuroprotection and circadian regulation. Its mechanism of action involves upregulation of serotonin synthesis enzymes and modulation of melatonin production pathways in pinealocytes. Research by Khavinson et al. published in Bulletin of Experimental Biology and Medicine demonstrated that Pinealon exhibited neuroprotective effects in cortical neuron cultures exposed to hypoxic and oxidative stress conditions, reducing cell death by up to 40% compared to controls. Additional studies showed that EDR peptide use in aged animal models helped restore circadian melatonin rhythms that had deteriorated with age. Work published in Advances in Gerontology indicated that Pinealon improved memory consolidation and learning capacity in senescence-accelerated mice. Compared to Epithalon (AEDG), another Khavinson bioregulator peptide targeting the pineal gland, Pinealon operates through distinct mechanisms. While Epithalon primarily activates telomerase and elongates telomeres, Pinealon focuses on direct neuroprotective gene regulation and serotonin pathway support. The two are sometimes studied in conjunction for comprehensive pineal gland and aging research. Lyophilized Pinealon should be stored at -20°C. Reconstitute with bacteriostatic water immediately before use and store at 2-8°C for up to 3 weeks. Researchers in gerontology, chronobiology, and neuroprotection are the primary investigators of this peptide, particularly those studying age-related cognitive decline and circadian disruption.

Frequently Asked Questions